サマリー

植込み型医療機器の世界市場は、2020年には918億6894万ドル、2030年には1790億3275万ドルに達し、2021年から2030年までのCAGRは7.2％を記録すると予測されています。インプラント型医療機器は、外科手術によって体内に移植されます。これらのインプラントは、損傷した身体器官の交換やサポート、身体器官の機能強化、正常な身体機能のエラーの検出などに使用されます。これらのデバイスは、人体に永久的または一時的に設置することができ、不要になったら取り外すことができる。これらの埋め込み型デバイスは、骨、組織、皮膚、セラミック、金属、およびその他の天然材料で構成されています。
慢性疾患の増加や人口の急速な高齢化が、市場の成長を促進しています。さらに、医療用インプラントの認知度向上と技術的進歩も市場の成長に寄与しています。しかし、インプラントのコストが高いことや、医療手術の分野で訓練を受けた専門家の不足が、市場成長の主な障壁となっています。逆に、償還政策の数の急増は、予測期間中に市場拡大のための有利な機会を提供すると期待されています。
植込み型医療機器市場は、製品および地域別に区分されています。製品別では、整形外科用インプラント、歯科用インプラント、乳房用インプラント、心臓血管用インプラント、眼内レンズ、その他のインプラントに分類されます。整形外科用インプラントはさらに、脊椎インプラントと再建型関節置換術に分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAで分析されています。

ステークホルダーにとっての主なメリット
本レポートでは、現在の市場動向と2020年から2030年までの将来予測を詳細に定量分析し、有力な市場機会の特定を支援します。
様々な地域の詳細な分析により、現在の動向を詳細に把握し、ステークホルダーが地域別の計画を策定できるようにすることが期待されます。
埋め込み型医療機器市場の成長を促進および抑制する要因の包括的な分析が提供されます。
様々な地域の広範な分析は、企業が戦略的にビジネスの動きを計画することを可能にする洞察を提供します。
主要な市場プレイヤーとその戦略は、市場の競争展望を理解するために分析されています。

ページTOPに戻る

目次

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Orthopedic Implants
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Cardiovascular Implants 
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Intraocular Lens 
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
4.5 Dental Implants
4.5.1 Key market trends, growth factors and opportunities
4.5.2 Market size and forecast, by region
4.5.3 Market analysis by country
4.6 Breast Implants
4.6.1 Key market trends, growth factors and opportunities
4.6.2 Market size and forecast, by region
4.6.3 Market analysis by country
4.7 Other Implants
4.7.1 Key market trends, growth factors and opportunities
4.7.2 Market size and forecast, by region
4.7.3 Market analysis by country
CHAPTER 5: IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION
5.1 Overview
5.1.1 Market size and forecast
5.2 North America
5.2.1 Key trends and opportunities
5.2.2 North America Market size and forecast, by Product
5.2.3 North America Market size and forecast, by country
5.2.3.1 U.S.
5.2.3.1.1 Market size and forecast, by Product
5.2.3.2 Canada
5.2.3.2.1 Market size and forecast, by Product
5.2.3.3 Mexico
5.2.3.3.1 Market size and forecast, by Product
5.3 Europe
5.3.1 Key trends and opportunities
5.3.2 Europe Market size and forecast, by Product
5.3.3 Europe Market size and forecast, by country
5.3.3.1 Germany
5.3.3.1.1 Market size and forecast, by Product
5.3.3.2 France
5.3.3.2.1 Market size and forecast, by Product
5.3.3.3 United Kingdom
5.3.3.3.1 Market size and forecast, by Product
5.3.3.4 Italy
5.3.3.4.1 Market size and forecast, by Product
5.3.3.5 Spain
5.3.3.5.1 Market size and forecast, by Product
5.3.3.6 Rest of Europe
5.3.3.6.1 Market size and forecast, by Product
5.4 Asia-Pacific
5.4.1 Key trends and opportunities
5.4.2 Asia-Pacific Market size and forecast, by Product
5.4.3 Asia-Pacific Market size and forecast, by country
5.4.3.1 Japan
5.4.3.1.1 Market size and forecast, by Product
5.4.3.2 China
5.4.3.2.1 Market size and forecast, by Product
5.4.3.3 Australia
5.4.3.3.1 Market size and forecast, by Product
5.4.3.4 India
5.4.3.4.1 Market size and forecast, by Product
5.4.3.5 South Korea
5.4.3.5.1 Market size and forecast, by Product
5.4.3.6 Rest of Asia-Pacific
5.4.3.6.1 Market size and forecast, by Product
5.5 LAMEA
5.5.1 Key trends and opportunities
5.5.2 LAMEA Market size and forecast, by Product
5.5.3 LAMEA Market size and forecast, by country
5.5.3.1 Brazil
5.5.3.1.1 Market size and forecast, by Product
5.5.3.2 Saudi Arabia
5.5.3.2.1 Market size and forecast, by Product
5.5.3.3 South Africa
5.5.3.3.1 Market size and forecast, by Product
5.5.3.4 Rest of LAMEA
5.5.3.4.1 Market size and forecast, by Product
CHAPTER 6: COMPANY LANDSCAPE
6.1. Introduction
6.2. Top winning strategies
6.3. Product Mapping of Top 10 Player
6.4. Competitive Dashboard
6.5. Competitive Heatmap
6.6. Key developments
CHAPTER 7: COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segments
7.1.4 Product portfolio
7.1.5 Business performance
7.1.6 Key strategic moves and developments
7.2 Biotronik SE and Co. KG
7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Product portfolio
7.2.5 Business performance
7.2.6 Key strategic moves and developments
7.3 Boston Scientific Corporation
7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Product portfolio
7.3.5 Business performance
7.3.6 Key strategic moves and developments
7.4 C. R. Bard, Inc.
7.4.1 Company overview
7.4.2 Company snapshot
7.4.3 Operating business segments
7.4.4 Product portfolio
7.4.5 Business performance
7.4.6 Key strategic moves and developments
7.5 Cardinal Health, Inc.
7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Operating business segments
7.5.4 Product portfolio
7.5.5 Business performance
7.5.6 Key strategic moves and developments
7.6 CONMED Corporation
7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Product portfolio
7.6.5 Business performance
7.6.6 Key strategic moves and developments
7.7 Globus Medical, Inc.
7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Product portfolio
7.7.5 Business performance
7.7.6 Key strategic moves and developments
7.8 Integra LifeSciences Holdings Corporation
7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Operating business segments
7.8.4 Product portfolio
7.8.5 Business performance
7.8.6 Key strategic moves and developments
7.9 Johnson and Johnson
7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments
7.9.4 Product portfolio
7.9.5 Business performance
7.9.6 Key strategic moves and developments
7.10 LivaNova PLC
7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Operating business segments
7.10.4 Product portfolio
7.10.5 Business performance
7.10.6 Key strategic moves and developments


LIST OF TABLES
TABLE 1. GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 2. IMPLANTABLE MEDICAL DEVICES MARKET REVENUE, FOR ORTHOPEDIC IMPLANTS, BY REGION , 2020-2030,($MILLION)
TABLE 3. IMPLANTABLE MEDICAL DEVICES MARKET ORTHOPEDIC IMPLANTS BY COUNTRY, 2020-2030,($MILLION)
TABLE 4. IMPLANTABLE MEDICAL DEVICES MARKET REVENUE, FOR CARDIOVASCULAR IMPLANTS , BY REGION , 2020-2030,($MILLION)
TABLE 5. IMPLANTABLE MEDICAL DEVICES MARKET CARDIOVASCULAR IMPLANTS  BY COUNTRY, 2020-2030,($MILLION)
TABLE 6. IMPLANTABLE MEDICAL DEVICES MARKET REVENUE, FOR INTRAOCULAR LENS , BY REGION , 2020-2030,($MILLION)
TABLE 7. IMPLANTABLE MEDICAL DEVICES MARKET INTRAOCULAR LENS  BY COUNTRY, 2020-2030,($MILLION)
TABLE 8. IMPLANTABLE MEDICAL DEVICES MARKET REVENUE, FOR DENTAL IMPLANTS, BY REGION , 2020-2030,($MILLION)
TABLE 9. IMPLANTABLE MEDICAL DEVICES MARKET DENTAL IMPLANTS BY COUNTRY, 2020-2030,($MILLION)
TABLE 10. IMPLANTABLE MEDICAL DEVICES MARKET REVENUE, FOR BREAST IMPLANTS, BY REGION , 2020-2030,($MILLION)
TABLE 11. IMPLANTABLE MEDICAL DEVICES MARKET BREAST IMPLANTS BY COUNTRY, 2020-2030,($MILLION)
TABLE 12. IMPLANTABLE MEDICAL DEVICES MARKET REVENUE, FOR OTHER IMPLANTS, BY REGION , 2020-2030,($MILLION)
TABLE 13. IMPLANTABLE MEDICAL DEVICES MARKET OTHER IMPLANTS BY COUNTRY, 2020-2030,($MILLION)
TABLE 14. IMPLANTABLE MEDICAL DEVICES MARKET, BY REGION, 2020-2030,($MILLION)
TABLE 15. NORTH AMERICA IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 16. NORTH AMERICA IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 17. U.S. IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 18. CANADA IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 19. MEXICO IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 20. EUROPE IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 21. EUROPE IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 22. GERMANY IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 23. FRANCE IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 24. UNITED KINGDOM IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 25. ITALY IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 26. SPAIN IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 27. REST OF EUROPE IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 28. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 29. ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 30. JAPAN IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 31. CHINA IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 32. AUSTRALIA IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 33. INDIA IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 34. SOUTH KOREA IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 35. REST OF ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 36. LAMEA IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT, 2020-2030,($MILLION)
TABLE 37. LAMEA IMPLANTABLE MEDICAL DEVICES MARKET, BY COUNTRY, 2020-2030,($MILLION)
TABLE 38. BRAZIL IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 39. SAUDI ARABIA IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 40. SOUTH AFRICA IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 41. REST OF LAMEA IMPLANTABLE MEDICAL DEVICES MARKET BY PRODUCT 2020-2030,($MILLION)
TABLE 42.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 43.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 44.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 45.ABBOTT LABORATORIES: NET SALES,
TABLE 46.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 47.BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT
TABLE 48.BIOTRONIK SE AND CO. KG: OPERATING SEGMENTS
TABLE 49.BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO
TABLE 50.BIOTRONIK SE AND CO. KG: NET SALES,
TABLE 51.BIOTRONIK SE AND CO. KG: KEY STRATERGIES
TABLE 52.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 53.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 54.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 55.BOSTON SCIENTIFIC CORPORATION: NET SALES,
TABLE 56.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 57.C. R. BARD, INC.: COMPANY SNAPSHOT
TABLE 58.C. R. BARD, INC.: OPERATING SEGMENTS
TABLE 59.C. R. BARD, INC.: PRODUCT PORTFOLIO
TABLE 60.C. R. BARD, INC.: NET SALES,
TABLE 61.C. R. BARD, INC.: KEY STRATERGIES
TABLE 62.CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
TABLE 63.CARDINAL HEALTH, INC.: OPERATING SEGMENTS
TABLE 64.CARDINAL HEALTH, INC.: PRODUCT PORTFOLIO
TABLE 65.CARDINAL HEALTH, INC.: NET SALES,
TABLE 66.CARDINAL HEALTH, INC.: KEY STRATERGIES
TABLE 67.CONMED CORPORATION: COMPANY SNAPSHOT
TABLE 68.CONMED CORPORATION: OPERATING SEGMENTS
TABLE 69.CONMED CORPORATION: PRODUCT PORTFOLIO
TABLE 70.CONMED CORPORATION: NET SALES,
TABLE 71.CONMED CORPORATION: KEY STRATERGIES
TABLE 72.GLOBUS MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 73.GLOBUS MEDICAL, INC.: OPERATING SEGMENTS
TABLE 74.GLOBUS MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 75.GLOBUS MEDICAL, INC.: NET SALES,
TABLE 76.GLOBUS MEDICAL, INC.: KEY STRATERGIES
TABLE 77.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 78.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: OPERATING SEGMENTS
TABLE 79.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT PORTFOLIO
TABLE 80.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: NET SALES,
TABLE 81.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY STRATERGIES
TABLE 82.JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 83.JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 84.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 85.JOHNSON AND JOHNSON: NET SALES,
TABLE 86.JOHNSON AND JOHNSON: KEY STRATERGIES
TABLE 87.LIVANOVA PLC: COMPANY SNAPSHOT
TABLE 88.LIVANOVA PLC: OPERATING SEGMENTS
TABLE 89.LIVANOVA PLC: PRODUCT PORTFOLIO
TABLE 90.LIVANOVA PLC: NET SALES,
TABLE 91.LIVANOVA PLC: KEY STRATERGIES


LIST OF FIGURES
FIGURE 1.IMPLANTABLE MEDICAL DEVICES MARKET SEGMENTATION
FIGURE 2.IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030
FIGURE 3.IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.IMPLANTABLE MEDICAL DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11.IMPLANTABLE MEDICAL DEVICES MARKET,BY PRODUCT,2020(%)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF ORTHOPEDIC IMPLANTS IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR IMPLANTS  IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF INTRAOCULAR LENS  IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF DENTAL IMPLANTS IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF BREAST IMPLANTS IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHER IMPLANTS IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030(%)
FIGURE 18.IMPLANTABLE MEDICAL DEVICES MARKET BY REGION,2020
FIGURE 19.U.S. IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 20.CANADA IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 21.MEXICO IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 22.GERMANY IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 23.FRANCE IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 24.UNITED KINGDOM IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 25.ITALY IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 26.SPAIN IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 27.REST OF EUROPE IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 28.JAPAN IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 29.CHINA IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 30.AUSTRALIA IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 31.INDIA IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 32.SOUTH KOREA IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 33.REST OF ASIA-PACIFIC IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 34.BRAZIL IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 35.SAUDI ARABIA IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 36.SOUTH AFRICA IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 37.REST OF LAMEA IMPLANTABLE MEDICAL DEVICES MARKET,2020-2030($MILLION)
FIGURE 38. TOP WINNING STRATEGIES, BY YEAR
FIGURE 39. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 40. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 41.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 42.COMPETITIVE DASHBOARD
FIGURE 43.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 44.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
FIGURE 45.BIOTRONIK SE AND CO. KG.: NET SALES ,($MILLION)
FIGURE 46.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
FIGURE 47.C. R. BARD, INC..: NET SALES ,($MILLION)
FIGURE 48.CARDINAL HEALTH, INC..: NET SALES ,($MILLION)
FIGURE 49.CONMED CORPORATION.: NET SALES ,($MILLION)
FIGURE 50.GLOBUS MEDICAL, INC..: NET SALES ,($MILLION)
FIGURE 51.INTEGRA LIFESCIENCES HOLDINGS CORPORATION.: NET SALES ,($MILLION)
FIGURE 52.JOHNSON AND JOHNSON.: NET SALES ,($MILLION)
FIGURE 53.LIVANOVA PLC.: NET SALES ,($MILLION)